All Stories

  1. Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation

    Article • ERJ Open Research, October 2022, European Respiratory Society (ERS)

    MD Manuela Funke

  2. Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges

    Article • ERJ Open Research, April 2022, European Respiratory Society (ERS)

    MD Manuela Funke

  3. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study

    Article • European Respiratory Journal, January 2021, European Respiratory Society (ERS)

    MD Manuela Funke

  4. Suggestions for improving clinical utility of future guidelines for diagnosis and management of idiopathic pulmonary fibrosis: results of a Delphi survey

    Article • European Respiratory Journal, January 2021, European Respiratory Society (ERS)

    MD Manuela Funke

  5. Azithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial

    Article • September 2020, European Respiratory Society (ERS)

    MD Manuela Funke

  6. Diagnosis of fibrotic hypersensitivity pneumonitis: Can an algorithm replace multidisciplinary team discussion?

    Article • September 2020, European Respiratory Society (ERS)

    MD Manuela Funke

  7. New radiological diagnostic criteria: impact on idiopathic pulmonary fibrosis diagnosis

    Article • European Respiratory Journal, July 2019, European Respiratory Society (ERS)

    MD Manuela Funke

  8. LPA in alveolarisation

    Article • American Journal of Respiratory Cell and Molecular Biology, July 2016, American Thoracic Society

    MD Manuela Funke

  9. Anti-Fibrotika als neue Therapie der idiopathischen Lungenfibrose

    Article • Therapeutische Umschau, February 2016, Hogrefe Publishing Group

    MD Manuela Funke